We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+15.09%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$9.27B
AUM Growth
+$916M
Cap. Flow
-$3.89M
Cap. Flow %
-0.04%
Top 10 Hldgs %
35.73%
Holding
278
New
28
Increased
73
Reduced
150
Closed
24

Top Buys

Rank Stock Value
1
GAP
The Gap Inc
GAP
+$73.5M
2
ROKU icon
Roku
ROKU
+$44.7M
3
AFRM icon
Affirm
AFRM
+$40.4M
4
OSCR icon
Oscar Health
OSCR
+$34.6M
5
GKOS icon
Glaukos
GKOS
+$23M

Sector Composition

Rank Sector Weight
1 Technology 28.65%
2 Consumer Discretionary 21.49%
3 Communication Services 15.02%
4 Healthcare 14.51%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTLS
51
DELISTED
Chart Industries
GTLS
$50M 0.54%
262,073
+10,251
+4% +$1.65M
CBOE icon
52
Cboe Global Markets
CBOE
$29.3B
$49.6M 0.54%
254,003
+33,550
+15% +$6.91M
DDOG icon
53
Datadog
DDOG
$82.6B
$48.6M 0.52%
340,160
-42,542
-11% -$5.84M
AFRM icon
54
Affirm
AFRM
$24.8B
$46.8M 0.5%
767,677
+727,298
+1,801% +$40.4M
XYZ
55
Block Inc
XYZ
$47.8B
$46.7M 0.5%
549,792
+5,390
+1% +$442K
FWRG icon
56
First Watch Restaurant Group
FWRG
$700M
$45.3M 0.49%
2,434,073
+4,436
+0.2% +$78.4K
SPNT icon
57
SiriusPoint
SPNT
$2.81B
$43.3M 0.47%
2,643,704
+299,114
+13% +$4.32M
WRBY icon
58
Warby Parker
WRBY
$3.18B
$40.7M 0.44%
1,681,717
-591,707
-26% -$12.1M
LOAR icon
59
Loar Holdings
LOAR
$6.05B
$40.6M 0.44%
549,748
-9,342
-2% -$766K
ARM icon
60
Arm
ARM
$255B
$40.4M 0.44%
327,843
-17,586
-5% -$2.48M
RIVN icon
61
Rivian
RIVN
$23B
$40.3M 0.43%
3,029,534
-569,686
-16% -$6.56M
SG icon
62
Sweetgreen
SG
$863M
$37.6M 0.41%
1,174,351
-1,592
-0.1% -$59.3K
BRBR icon
63
BellRing Brands
BRBR
$1.07B
$36.7M 0.4%
486,946
+56,450
+13% +$4.01M
INSP icon
64
Inspire Medical Systems
INSP
$2.15B
$34.8M 0.38%
187,693
-35,433
-16% -$6.88M
ZM icon
65
Zoom
ZM
$27.8B
$34.4M 0.37%
421,903
-7,110
-2% -$559K
MLM icon
66
Martin Marietta Materials
MLM
$36.2B
$34.4M 0.37%
66,572
+3,263
+5% +$1.85M
TNDM icon
67
Tandem Diabetes Care
TNDM
$1.17B
$33.6M 0.36%
931,894
+58,920
+7% +$1.99M
NOW icon
68
ServiceNow
NOW
$147B
$32.7M 0.35%
154,205
-16,510
-10% -$3.34M
BNTX icon
69
BioNTech
BNTX
$24.8B
$32.1M 0.35%
281,412
+5,581
+2% +$637K
RACE icon
70
Ferrari
RACE
$71.9B
$30.7M 0.33%
72,323
+13,626
+23% +$6.15M
IGIC icon
71
International General Insurance
IGIC
$1.1B
$29.8M 0.32%
1,254,865
-1,485
-0.1% -$33.9K
TLN
72
Talen Energy Corp
TLN
$13.7B
$29.7M 0.32%
147,432
-388
-0.3% -$75.7K
ASAN icon
73
Asana
ASAN
$2.21B
$27.9M 0.3%
1,377,704
+7,269
+0.5% +$115K
IBN icon
74
ICICI Bank
IBN
$105B
$27.7M 0.3%
928,559
+136,213
+17% +$4.11M
COCO icon
75
Vita Coco
COCO
$3.18B
$27.2M 0.29%
736,672
-903
-0.1% -$30.1K

Similar funds

Gilder Gagnon Howe & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Gilder Gagnon Howe & Co held 278 positions worth $9.27B, up 11% from $8.36B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Gilder Gagnon Howe & Co's Q4 2024 filing shows 28 new, 73 increased, 150 reduced and 24 closed positions. Its largest new stake was Roivant Sciences: 1,162,986 shares worth $13.8M. The largest sale was Lantheus, an estimated $36.8M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Gilder Gagnon Howe & Co's largest Q4 2024 buy was Roivant Sciences: 1,162,986 shares worth $13.8M.
  • Gilder Gagnon Howe & Co added most to The Gap Inc in Q4 2024, an estimated $73.5M increase.
  • Gilder Gagnon Howe & Co's biggest Q4 2024 reduction was Lantheus, cutting an estimated $36.8M.
  • Gilder Gagnon Howe & Co fully exited Newmont in Q4 2024, selling an estimated $21.1M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 36% of its $9.27B portfolio in Q4 2024.
  • Gilder Gagnon Howe & Co opened 28 new positions and closed 24 in Q4 2024.
  • Gilder Gagnon Howe & Co's portfolio value rose 11% quarter-over-quarter to $9.27B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2024, filed 14 Feb 2025.